News | May 26, 2025
Divi's Laboratories inks manufacturing and supply agreement with global pharma company
The company expects meaningful revenue contribution from this long-term agreement
The company expects meaningful revenue contribution from this long-term agreement
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Divestment is part of BASF’s strategic portfolio optimization
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
KRKA holds 51% and Laurus Labs holds 49% shareholding
To accelerate the development of next-generation radioconjugates to treat cancer
Cipla completes transfer of Generics Business Undertaking
Subscribe To Our Newsletter & Stay Updated
